Interleukin-6 Knockout Inhibits Senescence of Bone Mesenchymal Stem Cells in High-Fat Diet-Induced Bone Loss

• Published in: Frontiers in endocrinology (Lausanne) Vol. 11; p. 622950
• Main Authors: Li, Yujue, Lu, Lingyun, Xie, Ying, Chen, Xiang, Tian, Li, Liang, Yan, Li, Huifang, Zhang, Jie, Liu, Yi, Yu, Xijie
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19-02-2021
• Subjects: bone mesenchymal stem cells; Endocrinology; IL-6; obesity; osteoporosis; senecence; senecence; osteoporosis; IL-6; obesity; bone mesenchymal stem cells
• ISSN: 1664-2392; 1664-2392
• DOI: 10.3389/fendo.2020.622950

Obesity, a chronic low-grade inflammatory state, not only promotes bone loss, but also accelerates cell senescence. However, little is known about the mechanisms that link obesity, bone loss, and cell senescence. Interleukin-6 (IL-6), a pivotal inflammatory mediator increased during obesity, is a candidate for promoting cell senescence and an important part of senescence-associated secretory phenotype (SASP). Here, wild type (WT) and (IL-6 KO) mice were fed with high-fat diet (HFD) for 12 weeks. The results showed IL-6 KO mice gain less weight on HFD than WT mice. HFD induced trabecular bone loss, enhanced expansion of bone marrow adipose tissue (BMAT), increased adipogenesis in bone marrow (BM), and reduced the bone formation in WT mice, but it failed to do so in IL-6 KO mice. Furthermore, IL-6 KO inhibited HFD-induced clone formation of bone marrow cells (BMCs), and expression of senescence markers (p53 and p21). IL-6 antibody inhibited the activation of STAT3 and the senescence of bone mesenchymal stem cells (BMSCs) from WT mice
, while rescued IL-6 induced senescence of BMSCs from IL-6 KO mice through the STAT3/p53/p21 pathway. In summary, our data demonstrated that IL-6 KO may maintain the balance between osteogenesis and adipogenesis in BM, and restrain senescence of BMSCs in HFD-induced bone loss.